PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.51%
Revenue growth under 50% of MTDR's 24.49%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.37%
Gross profit growth under 50% of MTDR's 58.78%. Michael Burry would be concerned about a severe competitive disadvantage.
28.63%
EBIT growth below 50% of MTDR's 78.82%. Michael Burry would suspect deeper competitive or cost structure issues.
28.63%
Operating income growth under 50% of MTDR's 78.82%. Michael Burry would be concerned about deeper cost or sales issues.
165.94%
Net income growth above 1.5x MTDR's 56.24%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
167.80%
EPS growth above 1.5x MTDR's 57.14%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
167.80%
Diluted EPS growth above 1.5x MTDR's 57.14%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.12%
Share reduction while MTDR is at 1.13%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.16%
Reduced diluted shares while MTDR is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
7.28%
Dividend growth of 7.28% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
3.25%
OCF growth under 50% of MTDR's 77.72%. Michael Burry might suspect questionable revenue recognition or rising costs.
9.29%
FCF growth under 50% of MTDR's 41.98%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-83.85%
Negative 10Y revenue/share CAGR while MTDR stands at 716.84%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-6.77%
Negative 5Y CAGR while MTDR stands at 76.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-18.00%
Negative 3Y CAGR while MTDR stands at 78.95%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-82.83%
Negative 10Y OCF/share CAGR while MTDR stands at 487.42%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-15.24%
Negative 5Y OCF/share CAGR while MTDR is at 114.38%. Joel Greenblatt would question the firm’s operational model or cost structure.
-38.34%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
28.60%
Below 50% of MTDR's 314.37%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
126.34%
Below 50% of MTDR's 296.04%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
106.90%
3Y net income/share CAGR 50-75% of MTDR's 180.81%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
-72.96%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
8.36%
Below 50% of MTDR's 71.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-44.46%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-96.04%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.33%
Negative 5Y dividend/share CAGR while MTDR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-69.21%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
80.59%
Our AR growth while MTDR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-100.00%
Inventory is declining while MTDR stands at 46.89%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.03%
Negative asset growth while MTDR invests at 6.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.84%
Under 50% of MTDR's 7.15%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.33%
We’re deleveraging while MTDR stands at 0.01%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-10.83%
We cut SG&A while MTDR invests at 9.67%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.